Back to User profile » Dr Raweewan Lertwattanarak
Papers published by Dr Raweewan Lertwattanarak:
Determinants of Glycemic Control in Thai Adults with Insulin-Treated Type 2 Diabetes Mellitus: A Cross-Sectional Study
Riangkam C, Sanguanthammarong S, Lertwattanarak R
Patient Preference and Adherence 2025, 19:1909-1922
Published Date: 5 July 2025
Clinical Characteristics, Glycemic Control, and Microvascular Complications Compared Between Young-Onset Type 1 and Type 2 Diabetes Patients at Siriraj Hospital – A Tertiary Referral Center
Preechasuk L, Tantasuwan S, Likitmaskul S, Santiprabhob J, Lertbannaphong O, Plengvidhya N, Tangjittipokin W, Nitiyanant W, Lertwattanarak R
Diabetes, Metabolic Syndrome and Obesity 2022, 15:1375-1387
Published Date: 2 May 2022
Prevalence of and Factors Associated with Diabetic Retinopathy in Patients with Diabetes Mellitus at Siriraj Hospital – Thailand’s Largest National Tertiary Referral Center
Boonsaen T, Choksakunwong S, Lertwattanarak R
Diabetes, Metabolic Syndrome and Obesity 2021, 14:4945-4957
Published Date: 29 December 2021
Beta-cell function in type 2 diabetic patients who failed to maintain good glycemic status with a combination of maximum dosages of metformin and sulfonylurea
Kunavisarut T, Sriussadaporn S, Lertwattanarak R
Diabetes, Metabolic Syndrome and Obesity 2019, 12:761-770
Published Date: 21 May 2019
Withdrawal of sulfonylureas from patients with type 2 diabetes receiving long-term sulfonylurea and insulin combination therapy results in deterioration of glycemic control: a randomized controlled trial
Srivanichakorn W, Sriwijitkamol A, Kongchoo A, Sriussadaporn S, Plengvidhya N, Lertwattanarak R, Vannasaeng S, Thongtang N
Diabetes, Metabolic Syndrome and Obesity 2015, 8:137-145
Published Date: 2 March 2015